Abstract
Bacteroides fragilis is the leading cause of anaerobic bacteremia and sepsis1. Enterotoxigenic strains that produce B. fragilis toxin (BFT, fragilysin) contribute to colitis2 and intestinal malignancy3, yet are also isolated in bloodstream infection4,5. It is not known whether these strains harbor unique genetic determinants that confer virulence in extra-intestinal disease. We demonstrate that BFT contributes to sepsis in mice, and we identify a B. fragilis protease called fragipain (Fpn) that is required for the endogenous activation of BFT through the removal of its auto-inhibitory prodomain. Structural analysis of Fpn reveals a His–Cys catalytic dyad that is characteristic of C11-family cysteine proteases that are conserved in multiple pathogenic Bacteroides spp. and Clostridium spp. Fpn-deficient, enterotoxigenic B. fragilis has an attenuated ability to induce sepsis in mice; however, Fpn is dispensable in B. fragilis colitis, wherein host proteases mediate BFT activation. Our findings define a role for B. fragilis enterotoxin and its activating protease in the pathogenesis of bloodstream infection, which indicates a greater complexity of cellular targeting and activity of BFT than previously recognized. The expression of fpn by both toxigenic and nontoxigenic strains suggests that this protease may contribute to anaerobic sepsis in ways that extend beyond its role in toxin activation. It could thus potentially serve as a target for disease modification.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
A proteolytically activated antimicrobial toxin encoded on a mobile plasmid of Bacteroidales induces a protective response
Nature Communications Open Access 23 July 2022
-
Prevalence and antimicrobial susceptibility of enterotoxigenic extra-intestinal Bacteroides fragilis among 13-year collection of isolates in Kuwait
BMC Microbiology Open Access 15 January 2020
-
Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson’s disease
Journal of Neuroinflammation Open Access 27 June 2019
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout




References
Robert, R., Deraignac, A., Le Moal, G., Ragot, S. & Grollier, G. Prognostic factors and impact of antibiotherapy in 117 cases of anaerobic bacteraemia. Eur. J. Clin. Microbiol. Infect. Dis. 27, 671–678 (2008).
Rhee, K.J. et al. Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL/6 mice. Infect. Immun. 77, 1708–1718 (2009).
Wu, S. et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat. Med. 15, 1016–1022 (2009).
Kato, N., Kato, H., Watanabe, K. & Ueno, K. Association of enterotoxigenic Bacteroides fragilis with bacteremia. Clin. Infect. Dis. 23 (suppl. 1), S83–S86 (1996).
Claros, M.C. et al. Characterization of the Bacteroides fragilis pathogenicity island in human blood culture isolates. Anaerobe 12, 17–22 (2006).
Redondo, M.C., Arbo, M.D., Grindlinger, J. & Snydman, D.R. Attributable mortality of bacteremia associated with the Bacteroides fragilis group. Clin. Infect. Dis. 20, 1492–1496 (1995).
Ngo, J.T. et al. Population-based assessment of the incidence, risk factors, and outcomes of anaerobic bloodstream infections. Infection 41, 41–48 (2013).
Rocha, E.R. & Smith, C.J. Ferritin-like family proteins in the anaerobe Bacteroides fragilis: when an oxygen storm is coming, take your iron to the shelter. Biometals 26, 577–591 (2013).
Brook, I. & Frazier, E.H. Aerobic and anaerobic microbiology in intra-abdominal infections associated with diverticulitis. J. Med. Microbiol. 49, 827–830 (2000).
Vena, A. et al. Are incidence and epidemiology of anaerobic bacteremia really changing? Eur. J. Clin. Microbiol. Infect. Dis. 34, 1621–1629 (2015).
Ani, C., Farshidpanah, S., Bellinghausen Stewart, A. & Nguyen, H.B. Variations in organism-specific severe sepsis mortality in the United States: 1999–2008. Crit. Care Med. 43, 65–77 (2015).
Moghadamyeghaneh, Z. et al. A comparison of outcomes of emergent, urgent, and elective surgical treatment of diverticulitis. Am. J. Surg. 210, 838–845 (2015).
Snydman, D.R. et al. Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005–2007). Clin. Infect. Dis. 50 (suppl. 1), S26–S33 (2010).
Kasper, D.L., Onderdonk, A.B., Crabb, J. & Bartlett, J.G. Protective efficacy of immunization with capsular antigen against experimental infection with Bacteroides fragilis. J. Infect. Dis. 140, 724–731 (1979).
Hartmeyer, G.N., Sóki, J., Nagy, E. & Justesen, U.S. Multidrug-resistant Bacteroides fragilis group on the rise in Europe? J. Med. Microbiol. 61, 1784–1788 (2012).
Wang, F.D., Liao, C.H., Lin, Y.T., Sheng, W.H. & Hsueh, P.R. Trends in the susceptibility of commonly encountered clinically significant anaerobes and susceptibilities of blood isolates of anaerobes to 16 antimicrobial agents, including fidaxomicin and rifaximin, 2008–2012, northern Taiwan. Eur. J. Clin. Microbiol. Infect. Dis. 33, 2041–2052 (2014).
Franco, A.A. et al. Molecular evolution of the pathogenicity island of enterotoxigenic Bacteroides fragilis strains. J. Bacteriol. 181, 6623–6633 (1999).
Moncrief, J.S. et al. The enterotoxin of Bacteroides fragilis is a metalloprotease. Infect. Immun. 63, 175–181 (1995).
Franco, A.A. et al. Cloning and characterization of the Bacteroides fragilis metalloprotease toxin gene. Infect. Immun. 65, 1007–1013 (1997).
Wu, S., Lim, K.C., Huang, J., Saidi, R.F. & Sears, C.L. Bacteroides fragilis enterotoxin cleaves the zonula adherens protein, E-cadherin. Proc. Natl. Acad. Sci. USA 95, 14979–14984 (1998).
Goulas, T., Arolas, J.L. & Gomis-Rüth, F.X. Structure, function and latency regulation of a bacterial enterotoxin potentially derived from a mammalian adamalysin/ADAM xenolog. Proc. Natl. Acad. Sci. USA 108, 1856–1861 (2011).
Kim, J.M. et al. Nuclear factor-κB activation pathway in intestinal epithelial cells is a major regulator of chemokine gene expression and neutrophil migration induced by Bacteroides fragilis enterotoxin. Clin. Exp. Immunol. 130, 59–66 (2002).
Powers, M.E., Kim, H.K., Wang, Y. & Bubeck Wardenburg, J. ADAM10 mediates vascular injury induced by Staphylococcus aureus α-hemolysin. J. Infect. Dis. 206, 352–356 (2012).
Inoshima, I. et al. A Staphylococcus aureus pore-forming toxin subverts the activity of ADAM10 to cause lethal infection in mice. Nat. Med. 17, 1310–1314 (2011).
Powers, M.E., Becker, R.E., Sailer, A., Turner, J.R. & Bubeck Wardenburg, J. Synergistic action of Staphylococcus aureus α-toxin on platelets and myeloid lineage cells contributes to lethal sepsis. Cell Host Microbe 17, 775–787 (2015).
Franco, A.A., Buckwold, S.L., Shin, J.W., Ascon, M. & Sears, C.L. Mutation of the zinc-binding metalloprotease motif affects Bacteroides fragilis toxin activity but does not affect propeptide processing. Infect. Immun. 73, 5273–5277 (2005).
Van Tassell, R.L., Lyerly, D.M. & Wilkins, T.D. Purification and characterization of an enterotoxin from Bacteroides fragilis. Infect. Immun. 60, 1343–1350 (1992).
Labrou, N.E. & Rigden, D.J. The structure-function relationship in the clostripain family of peptidases. Eur. J. Biochem. 271, 983–992 (2004).
McLuskey, K. & Mottram, J.C. Comparative structural analysis of the caspase family with other clan CD cysteine peptidases. Biochem. J. 466, 219–232 (2015).
Dargatz, H., Diefenthal, T., Witte, V., Reipen, G. & von Wettstein, D. The heterodimeric protease clostripain from Clostridium histolyticum is encoded by a single gene. Mol. Gen. Genet. 240, 140–145 (1993).
Shokhen, M., Khazanov, N. & Albeck, A. Challenging a paradigm: theoretical calculations of the protonation state of the Cys25-His159 catalytic diad in free papain. Proteins 77, 916–926 (2009).
Vivares, D., Arnoux, P. & Pignol, D. A papain-like enzyme at work: native and acyl-enzyme intermediate structures in phytochelatin synthesis. Proc. Natl. Acad. Sci. USA 102, 18848–18853 (2005).
Wei, D., Huang, X., Liu, J., Tang, M. & Zhan, C.G. Reaction pathway and free energy profile for papain-catalyzed hydrolysis of N-acetyl-Phe-Gly 4-nitroanilide. Biochemistry 52, 5145–5154 (2013).
Angus, D.C. & van der Poll, T. Severe sepsis and septic shock. N. Engl. J. Med. 369, 840–851 (2013).
Ortega, E., Abriouel, H., Lucas, R. & Gálvez, A. Multiple roles of Staphylococcus aureus enterotoxins: pathogenicity, superantigenic activity, and correlation to antibiotic resistance. Toxins (Basel) 2, 2117–2131 (2010).
Mayer, C.L., Leibowitz, C.S., Kurosawa, S. & Stearns-Kurosawa, D.J. Shiga toxins and the pathophysiology of hemolytic uremic syndrome in humans and animals. Toxins (Basel) 4, 1261–1287 (2012).
Inoshima, N., Wang, Y. & Bubeck Wardenburg, J. Genetic requirement for ADAM10 in severe Staphylococcus aureus skin infection. J. Invest. Dermatol. 132, 1513–1516 (2012).
Cui, L. et al. An ADAM10 promoter polymorphism is a functional variant in severe sepsis patients and confers susceptibility to the development of sepsis. Crit. Care 19, 73 (2015).
Rawlings, N.D., Barrett, A.J. & Bateman, A. MEROPS: the database of proteolytic enzymes, their substrates and inhibitors. Nucleic Acids Res. 40, D343–D350 (2012).
Comstock, L.E. et al. Analysis of a capsular polysaccharide biosynthesis locus of Bacteroides fragilis. Infect. Immun. 67, 3525–3532 (1999).
Melton-Celsa, A.R., Darnell, S.C. & O'Brien, A.D. Activation of Shiga-like toxins by mouse and human intestinal mucus correlates with virulence of enterohemorrhagic Escherichia coli O91:H21 isolates in orally infected, streptomycin-treated mice. Infect. Immun. 64, 1569–1576 (1996).
Goodman, A.L. et al. Identifying genetic determinants needed to establish a human gut symbiont in its habitat. Cell Host Microbe 6, 279–289 (2009).
Koropatkin, N.M., Martens, E.C., Gordon, J.I. & Smith, T.J. Starch catabolism by a prominent human gut symbiont is directed by the recognition of amylose helices. Structure 16, 1105–1115 (2008).
Winter, G. xia2: an expert system for macromolecular crystallography data reduction. J. Appl. Cryst. 43, 186–190 (2010).
Kabsch, W. Xds. Acta Crystallogr. D Biol. Crystallogr. 66, 125–132 (2010).
Evans, P.R. & Murshudov, G.N. How good are my data and what is the resolution? Acta Crystallogr. D Biol. Crystallogr. 69, 1204–1214 (2013).
Morin, A. et al. Collaboration gets the most out of software. eLife 2, e01456 (2013).
Adams, P.D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213–221 (2010).
Arnold, K., Bordoli, L., Kopp, J. & Schwede, T. The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 22, 195–201 (2006).
Emsley, P., Lohkamp, B., Scott, W.G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486–501 (2010).
Acknowledgements
This work was supported by the Department of Pediatrics at the University of Chicago and with a Pilot and Feasibility Award from the Digestive Diseases Research Core Center at the University of Chicago to J.B.W. (NIDDK P30DK42086); by a Burroughs Wellcome Foundation Investigators in the Pathogenesis of Infectious Disease Fellowship (J.B.W.); and by the US National Institutes of Health Medical Scientist Training Program at the University of Chicago (GM007281 to V.M.C. and A.L.H.). We thank D. Hecht (Loyola University) for his generous guidance on the establishment of a B. fragilis program and for B. fragilis strain 638R/TM4000; D. Missiakas (University of Chicago) for α-RpoA antisera; J. Gordon (Washington University) for the pSAM-Bt and pKNOCK vectors and Escherichia coli S17 strain; and Y. Fu (University of Texas Southwestern Medical Center) for germ-free mice.
Author information
Authors and Affiliations
Contributions
V.M.C. developed the experimental concepts and approach, generated all bacterial strains, performed transposon-mutagenesis screening and studies on colonic epithelial injury and sepsis in vivo and in vitro, and contributed to writing the manuscript. J.H. generated and analyzed the Fpn crystal structure and contributed to writing the manuscript. A.L.H. contributed essential bacterial genetic reagents and expertise. W.P.T. performed studies on the endothelium. J.R.T. performed pathology analysis of colonic tissues. S.C. analyzed the Fpn crystal structure and contributed to writing the manuscript. J.B.W. developed the experimental concepts and approach and contributed to writing the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–5 and Supplementary Tables 1–2 (PDF 1595 kb)
Source data
Source data for Supplementary Figures 1, 3, 4 (XLS 35 kb)
Source data
Rights and permissions
About this article
Cite this article
Choi, V., Herrou, J., Hecht, A. et al. Activation of Bacteroides fragilis toxin by a novel bacterial protease contributes to anaerobic sepsis in mice. Nat Med 22, 563–567 (2016). https://doi.org/10.1038/nm.4077
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.4077
This article is cited by
-
A proteolytically activated antimicrobial toxin encoded on a mobile plasmid of Bacteroidales induces a protective response
Nature Communications (2022)
-
The role and molecular mechanism of gut microbiota in Graves’ orbitopathy
Journal of Endocrinological Investigation (2022)
-
Prevalence and antimicrobial susceptibility of enterotoxigenic extra-intestinal Bacteroides fragilis among 13-year collection of isolates in Kuwait
BMC Microbiology (2020)
-
Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson’s disease
Journal of Neuroinflammation (2019)
-
Learning from bacterial competition in the host to develop antimicrobials
Nature Medicine (2018)